🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study in AML patients is to test whether vadastuximab t...
Status
Terminated
Location
University of Arkansas for Medical Sciences
Start Date
2016-05
Trial ID
NCT02785900
Treatments Being Tested
This study will examine the safety profile of vadastuximab talirine (SGN-CD...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-12
Trial ID
NCT02326584
This study will examine the safety and anti-leukemic profile of SGN-CD33A (...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2015-11
Trial ID
NCT02614560
Treatments Being Tested
This study will examine the safety profile of vadastuximab talirine (SGN-CD...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2013-07
Trial ID
NCT01902329
This is a phase 1/2 study to evaluate the combination of vadastuximab talir...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2016-02
Trial ID
NCT02706899
Treatments Being Tested